for the treatment of persistent hypotension during early burn resuscitation. [5] [6] [7] While these resuscitation algorithms empirically address the well-recognized risk of fluid overload (over-resuscitation or "fluid creep"), the effects of burn injury on intrinsic vascular function and on the cardiovascular responsiveness to vasoactive agents remain poorly understood. [8] [9] [10] [11] [12] Such information, however, could provide the pathophysiologic basis for the use of a particular vasoactive drug and guide in the development of resuscitation strategies that are optimized for the specific pathophysiology of the burned patient.
Thus, the aims of the present study were to determine whether burn injury alters cardiovascular reactivity to vasoactive drugs and to delineate whether burn injury affects intrinsic vascular function. To address these aims, we used a well-established rat scald burn model to determine the mean arterial blood pressure (MAP) response to aVP and phenylephrine, a selective α 1 -adrenergic receptor agonist, in vivo and pressure myography to assess possible burninduced changes in the vasopressor reactivity of isolated mesenteric resistance arteries.
METHODS

Animal Protocol
All procedures were performed according to National Institutes of Health Guidelines for Use of Laboratory Animals and approved by the Loyola Institutional Animal Care and Use Committee and the Department of Defense Animal Care and Use Review Office. Male Sprague-Dawley rats (325-350 g body weight, Harlan, Indianapolis, IN) were anesthetized with 2.5% isoflurane (Patterson Veterinary, Devens, MA), shaved, and placed into a template that exposes a dorsal body area corresponding to 30% of their TBSA. A full thickness burn was then induced by immersion of the dorsal skin into boiling water for 17 seconds, as described previously. 13, 14 Sham animals were treated as described before, except that their dorsal surface was immersed in tepid water. Animals were then resuscitated with crystalloid solution i.p. using a modified Parkland formula (4 ml/kg/%TBSA, 4 ml/ kg/%TBSA divided over four equal dosages) during the first 48 hours after burn injury. All animals at the end of the experimental period were killed (isoflurane inhalation, bilateral pneumothorax).
In Vivo Testing of Cardiovascular Responsiveness
In vivo testing of the cardiovascular responsiveness to vasoactive drugs was performed as described previously.
15 Animals (n = 4-9/group and vasopressor) after sham procedure and at 24, 72, 96, and 168 hours post burn were reanesthetized (2.5% isoflurane) and instrumented with central venous and arterial catheters that were placed into the femoral vessels. Rats were then resuscitated with crystalloids (3-5 ml of Lactated Ringer's solution) to a MAP ≥80 mm Hg. Hemodynamic stability was assumed when MAP remained above 80 mm Hg for 15 minutes.
Animals received intravenous bolus injections of nine increasing doses of phenylephrine (2.5 μg/kg-5 mg/kg, Sigma, St. Louis, MO) or 19 increasing doses of aVP (0.01 pg/kg-25 μg/ kg, Sigma) in 0.5 ml of normal saline in 5-minute intervals. MAP was recorded at 10-second intervals for the duration of the experimental period. At the end of the experimental period, animals were killed (isoflurane inhalation, bilateral pneumothorax). For each dose of phenylephrine or aVP, the area under the MAP curve was calculated with the GraphPad-Prism 6 software and dose response curves were generated.
Pressure Myography
Pressure myography was performed as described previously 16 with slight modifications. In brief, animals were killed, the mesentery was immediately removed, and placed in 130 mM NaCl, 4.7 mM KCl, 1.18 mM KH 2 PO 4 , 1.17 mM MgSO 4 ·7 H 2 O, 14.9 mM NaHCO 3 , 5.5 mM d-glucose, 0.026 mM EDTA, and 1.16 CaCl 2 . Third or fourth order mesenteric arteries, which contribute significantly to vascular resistance, 17, 18 were then dissected free from the mesentery, mounted with 11-0 nylon sutures onto two glass cannulae of a pressure myography system (Model 110P, DMT-USA, Ann Arbor, MI) and pressurized to 80 mm Hg. The vessel bath solution and intralumunal solution were as described before. All solutions were aerated with 95% O 2 and 5% CO 2 for 20 minutes before use and the vessel bath solution was continuously aerated during the experiments. The outer diameter of the pressurized artery was then continuously measured and recorded via digital videoedge detection utilizing the MyoVIEW 3.1.1 software (DMT-USA). Increasing concentrations of aVP and phenylephrine were then added to the organ bath in 7-minute intervals. Vasoconstriction after each dose of vasopressor was calculated as percentage of the outer vessel diameter measured in the absence of vasopressors at the beginning of the experiment.
Data Analyses and Statistics
Data are given as mean ± SEM. Area under curve and nonlinear regression analyses were calculated using the GraphPad Prism 6 Program (GraphPad Software, LaJolla, CA). Best-fit values were compared with the extra sum-of-squares F test. A twotailed P < .05 was considered significant.
RESULTS
A representative MAP curve from a dose-response experiment with phenylephrine is shown in Figure 1 . As a quantifiable marker of the blood pressure response to phenylephrine or aVP, we determined the area under the mean MAP curve for each dose of vasopressor and generated dose-response curves. Figure 2A -D shows the dose-response curves for phenylephrine in animals after sham procedure and in animals at the various time points after burns. The phenylephrine dose-response curve was shifted to the right at 24 hours post burn and normalized thereafter. The potency of phenylephrine was significantly reduced 24 hours post burn (EC 50 : sham, 201 ± 11 μg/kg; 24 hours post burn, 443 ± 14 μg/kg; P < .05) and gradually normalized at later time points (393 ± 13 pg/kg, 375 ± 15 pg/kg, and 247 ± 9 μg/kg at 72, 96, and 168 hours post burn, respectively, P > .05 vs baseline; Figure 2E ). The efficacy of phenylephrine transiently increased by 22% at 96 hours post burn (top plateau: sham, 365 ± 22 mm Hg x seconds; 96 hours post burn-446 ± 25 mm Hg x seconds; P < .05; Figure 2F ). The Hill slopes of the phenylephrine dose-response curves were indistinguishable at all time points (P > .05 vs sham for all time points, not shown).
The dose-response curves for aVP at the various time points are shown in Figure 3A -D. In contrast to the dose-response curves for phenylephrine, the aVP dose-response curve was shifted to the left at 24 hours post burn and normalized at subsequent time points. Potency ( Figure 3E ) and efficacy (Figure 3F ) of aVP were significantly increased 24 hours post burn and normalized within 168 hours post burn (EC 50 : sham, 315 ± 7 ng/kg; 24 hours post burn, 131 ± 3 ng/kg; P < .05; top plateau: sham, 220 ± 11 mm Hg × seconds; 24 hours post burn, 267 ± 11 mm Hg × seconds; P < .05). The Hill slopes of the arginine vasopressin dose-response curves were not significantly altered after burns (P > .05 vs sham for all time points, not shown).
To assess whether the observed changes of the blood pressure response to phenylephrine and aVP after burns are accompanied by alterations of intrinsic vascular function, we then utilized pressure myography to test the responsiveness of isolated mesenteric resistance arteries that were pressurized to 80 mm Hg. The phenylephrine dose-response curves of mesenteric arteries from uninjured animals and animals at 24 and 168 hours post burn are shown in Figure 4A , and the corresponding EC 50 concentrations, the top plateau values, and Hill slopes are shown in Figure 4B -D. The reactivity of isolated arteries to phenylephrine stimulation was not significantly altered after burns. Nevertheless, it should be noted that Hill slopes increased from 0.86 ± 0.34 at baseline to 1.47 ± 0.33 and 2.3 ± 0.8 at 24 and 168 hours post burn, respectively. These changes, however, did not reach a level of statistical significance.
The aVP dose-response curves of isolated arteries from uninjured animals and animals after burns are shown in Figure 5A . Similar to the in vivo blood pressure response to aVP, the dose-response of isolated arteries to aVP was shifted to the left at 24 hours post burn and indistinguishable from uninjured animals at 168 hours after burns. While the potency of aVP to induce vasoconstriction in arteries harvested 24 hours post burn was significantly increased ( Figure 5B), efficacy ( Figure 5D ) and Hill slopes ( Figure 5C ) of the dose response curves were unchanged, as compared with arteries form control animals. The reactivity of arteries from animals 168 hours post burn was comparable with those from uninjured animals. 
DISCUSSION
In this study, we provide an evaluation of burninduced changes in systemic cardiovascular responsiveness and intrinsic resistance artery responsiveness to the α 1 -adrenergic receptor agonist phenylephrine and the vasopressin receptor agonist aVP. There are several new findings from this study. First, burn injuries are associated with alterations in intrinsic vascular function. Second, systemic cardiovascular responsiveness and intrinsic resistance artery responsiveness to aVP are increased 24 hours post burn, resulting in a 2-to 3-fold higher potency of the vasoconstrictor and blood pressure effects of aVP. Third, the potency of phenylephrine to increase MAP is 2-fold reduced 24 hours post burn.
As adverse effects of over-resuscitation are being increasingly recognized in trauma and burn patients, the concept of early pressure support resuscitation in patients requiring excessive amounts of crystalloids and/or colloids has gained particular attention. [9] [10] [11] [12] 19, 20 Moreover, a standard low dose of vasopressin followed by norepinephrine titrated by effect has been incorporated in several published resuscitation algorithms for the difficult to resuscitate hypotensive burn patient. [5] [6] [7] This treatment strategy has been largely adapted from septic shock patients, in which endogenous aVP deficiency contributes to vasodilatory shock and exogenous aVP has a significant norepinephrine sparing effect. [21] [22] [23] It should be noted, however, that sufficient evidence supporting the use of one vasopressor or any combination of vasopressors over other vasopressors is currently lacking and that early vasopressor use after injury remains controversial. [24] [25] [26] [27] [28] [29] Nevertheless, information on early burn-induced changes in cardiovascular reactivity to various vasopressors is sparse and, to the best of our knowledge, possible changes in the reactivity of resistance arteries after burns have not been studied previously. Although norepinephrine is used more frequently than phenylephrine in patients, it is a nonselective agonist of α-and β-adrenoceptors. 30 As the use of norepinephrine would thus not permit direct conclusions on vascular α 1 -adrenergic receptor function in vivo and in isolated arteries, we used the selective α 1 -adrenoceptor agonist phenylephrine in our experiments. 30 It is well established that burn injuries lead to a rapid and pronounced stress response with significantly increased plasma concentrations of endogenous aVP and catecholamines. [31] [32] [33] Furthermore, vasopressin and adrenergic receptors are known to undergo agonist-induced internalization. 34, 35 Thus, the finding that the potency of phenylephrine to increase MAP was reduced 24 hours after burns is in agreement with a post burn catecholamine surge. Our observation that the responsiveness of isolated resistance arteries to phenylephrine is not significantly altered at the same time point after burns is consistent with previous observations from aortic ring preparations that were also tested in catecholamine-free organ solutions. 36 These data suggest that intrinsic vascular α-adrenergic receptor function is not affected by the thermal injury, despite attenuation of the in vivo blood pressure response to phenylephrine.
Based on the foregoing, it was unexpected that the potency and efficacy of aVP to increase MAP was significantly increased at 24 hours post burn. As the potency of aVP to induce vasoconstriction in isolated arteries was also increased to a comparable degree and at the same time point post burn, these findings provide initial evidence for burn-induced alterations in the intrinsic function of resistance arteries, which Furthermore, our data show that the sensitivity of the blood pressure response to α-adrenergic and vasopressin receptor stimulation is diametrically opposed early after burns. Our observations are similar, but not identical, to previous findings in a long-term rodent model of sepsis, in which the blood pressure response and the efficacy to contract isolated arteries of norepinephrine were reduced in septic animals, whereas the blood pressure response was maintained and the potency of aVP to contract arteries was enhanced. 37 Several mechanisms could be responsible for the observed changes in vascular α-adrenergic and vasopressin receptor sensitivity after burns or sepsis. One obvious possibility is that burn or sepsis may lead to alterations in receptor expression levels. Alternatively, burn or sepsis may affect vascular α-adrenergic and vasopressin receptor sensitivity through alterations of receptor heteromerization on the cell surface or via interference with their downstream signaling events. 15, 16 As reliable analyses of receptor densities, heteromeric receptor complexes or receptor signaling properties in intact arteries appear currently impossible, further experimentation with isolated vascular smooth muscle cells is required to test these hypotheses. Such experiments, however, are beyond the scope of this study. Thus, the exact molecular mechanisms underlying these effects remain to be determined in future studies.
In conclusion, the findings from this study suggest that burn injury results in a differential regulation of the vasopressor and blood pressure effects of α-adrenergic and vasopressin receptor agonists. While the potency of α-adrenergic receptor agonists to increase MAP is reduced 24 hours post burn, potency and efficacy of aVP are increased. Furthermore, our observations suggest that burn injury sensitizes intrinsic vasopressin receptor reactivity in resistance arteries. The observed changes occur at a critical time period during which stabilization of hemodynamics and maintenance of sufficient urine output are of major clinical relevance. It is possible that the changes in cardiovascular and intrinsic vascular function might be even more pronounced at time points closer to the burn injury than 24 hours. As our observations, however, were not anticipated, we did not include earlier post burn time points in the initial study design.
Because vascular resistance is inversely proportional to the fourth power of the vessel radius (Hagen-Poiseuille equation), the observed increased potency of aVP 24 hours after burns can explain the therapeutic efficacy of low-dose vasopressin to stabilize hemodynamics in burn patients. Thus, our findings now provide a pathophysiologic rationale for the use of arginine vasopressin in an initial attempt to stabilize hemodynamics in burn patients who remain hypotensive despite crystalloid and/or colloid resuscitation. These data may help to optimize vasopressor use in the difficult to resuscitate burn patient and to reduce the complications associated with fluid overload. Whether early vasopressor support in the difficult to resuscitate burn patient will improve outcomes, however, remains to be determined in prospective clinical trials.
